nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP1A2—Anagrelide—hematologic cancer	0.0487	0.0696	CbGbCtD
Alosetron—CYP2E1—Thalidomide—hematologic cancer	0.0311	0.0446	CbGbCtD
Alosetron—CYP2C9—Bexarotene—hematologic cancer	0.0304	0.0435	CbGbCtD
Alosetron—CYP2E1—Dacarbazine—hematologic cancer	0.0268	0.0383	CbGbCtD
Alosetron—CYP1A2—Carmustine—hematologic cancer	0.0256	0.0366	CbGbCtD
Alosetron—CYP2C9—Idarubicin—hematologic cancer	0.0252	0.036	CbGbCtD
Alosetron—CYP1A2—Methoxsalen—hematologic cancer	0.0217	0.0311	CbGbCtD
Alosetron—CYP2E1—Mitoxantrone—hematologic cancer	0.0208	0.0297	CbGbCtD
Alosetron—CYP1A2—Bortezomib—hematologic cancer	0.0207	0.0296	CbGbCtD
Alosetron—CYP1A2—Daunorubicin—hematologic cancer	0.0198	0.0283	CbGbCtD
Alosetron—CYP1A2—Alitretinoin—hematologic cancer	0.0194	0.0277	CbGbCtD
Alosetron—CYP2C9—Bortezomib—hematologic cancer	0.0186	0.0267	CbGbCtD
Alosetron—CYP1A2—Thalidomide—hematologic cancer	0.018	0.0258	CbGbCtD
Alosetron—CYP3A4—Bexarotene—hematologic cancer	0.0177	0.0253	CbGbCtD
Alosetron—CYP3A4—Busulfan—hematologic cancer	0.0164	0.0235	CbGbCtD
Alosetron—CYP3A4—Lomustine—hematologic cancer	0.0164	0.0235	CbGbCtD
Alosetron—CYP2C9—Thalidomide—hematologic cancer	0.0162	0.0232	CbGbCtD
Alosetron—CYP1A2—Dacarbazine—hematologic cancer	0.0155	0.0222	CbGbCtD
Alosetron—CYP2C9—Teniposide—hematologic cancer	0.0155	0.0222	CbGbCtD
Alosetron—CYP1A2—Imatinib—hematologic cancer	0.0151	0.0217	CbGbCtD
Alosetron—CYP3A4—Thiotepa—hematologic cancer	0.0146	0.021	CbGbCtD
Alosetron—CYP2C9—Ifosfamide—hematologic cancer	0.0143	0.0204	CbGbCtD
Alosetron—CYP2C9—Imatinib—hematologic cancer	0.0137	0.0195	CbGbCtD
Alosetron—CYP2E1—Etoposide—hematologic cancer	0.0131	0.0188	CbGbCtD
Alosetron—CYP2C9—Nilotinib—hematologic cancer	0.0124	0.0178	CbGbCtD
Alosetron—CYP1A2—Dasatinib—hematologic cancer	0.0122	0.0174	CbGbCtD
Alosetron—CYP3A4—Methoxsalen—hematologic cancer	0.0114	0.0163	CbGbCtD
Alosetron—CYP3A4—Bortezomib—hematologic cancer	0.0108	0.0155	CbGbCtD
Alosetron—CYP2E1—Dexamethasone—hematologic cancer	0.0108	0.0154	CbGbCtD
Alosetron—CYP3A4—Daunorubicin—hematologic cancer	0.0104	0.0148	CbGbCtD
Alosetron—CYP3A4—Cytarabine—hematologic cancer	0.00914	0.0131	CbGbCtD
Alosetron—CYP3A4—Teniposide—hematologic cancer	0.009	0.0129	CbGbCtD
Alosetron—CYP3A4—Ifosfamide—hematologic cancer	0.00831	0.0119	CbGbCtD
Alosetron—CYP3A4—Imatinib—hematologic cancer	0.00794	0.0114	CbGbCtD
Alosetron—CYP1A2—Etoposide—hematologic cancer	0.00758	0.0108	CbGbCtD
Alosetron—CYP3A4—Ruxolitinib—hematologic cancer	0.00747	0.0107	CbGbCtD
Alosetron—CYP3A4—Nilotinib—hematologic cancer	0.00721	0.0103	CbGbCtD
Alosetron—CYP3A4—Vinorelbine—hematologic cancer	0.00715	0.0102	CbGbCtD
Alosetron—CYP2C9—Cisplatin—hematologic cancer	0.00695	0.00995	CbGbCtD
Alosetron—CYP3A4—Triamcinolone—hematologic cancer	0.00654	0.00936	CbGbCtD
Alosetron—CYP3A4—Dasatinib—hematologic cancer	0.00637	0.00912	CbGbCtD
Alosetron—CYP3A4—Mitoxantrone—hematologic cancer	0.0063	0.00901	CbGbCtD
Alosetron—CYP2C9—Dexamethasone—hematologic cancer	0.00561	0.00803	CbGbCtD
Alosetron—CYP3A4—Betamethasone—hematologic cancer	0.00561	0.00803	CbGbCtD
Alosetron—CYP3A4—Prednisolone—hematologic cancer	0.00554	0.00792	CbGbCtD
Alosetron—CYP3A4—Prednisone—hematologic cancer	0.00523	0.00748	CbGbCtD
Alosetron—CYP3A4—Irinotecan—hematologic cancer	0.00496	0.00709	CbGbCtD
Alosetron—CYP3A4—Vinblastine—hematologic cancer	0.00441	0.00631	CbGbCtD
Alosetron—CYP3A4—Vincristine—hematologic cancer	0.00433	0.0062	CbGbCtD
Alosetron—CYP3A4—Etoposide—hematologic cancer	0.00397	0.00568	CbGbCtD
Alosetron—CYP3A4—Dexamethasone—hematologic cancer	0.00326	0.00467	CbGbCtD
Alosetron—CYP3A4—Doxorubicin—hematologic cancer	0.00271	0.00388	CbGbCtD
Alosetron—Hyperglycaemia—Epirubicin—hematologic cancer	5.64e-05	0.000203	CcSEcCtD
Alosetron—Nausea—Bortezomib—hematologic cancer	5.62e-05	0.000202	CcSEcCtD
Alosetron—Hypersensitivity—Mitoxantrone—hematologic cancer	5.61e-05	0.000202	CcSEcCtD
Alosetron—Hypersensitivity—Irinotecan—hematologic cancer	5.61e-05	0.000202	CcSEcCtD
Alosetron—Asthenia—Vincristine—hematologic cancer	5.61e-05	0.000202	CcSEcCtD
Alosetron—Vomiting—Thiotepa—hematologic cancer	5.61e-05	0.000202	CcSEcCtD
Alosetron—Nausea—Bleomycin—hematologic cancer	5.58e-05	0.0002	CcSEcCtD
Alosetron—Rash—Thiotepa—hematologic cancer	5.56e-05	0.0002	CcSEcCtD
Alosetron—Dermatitis—Thiotepa—hematologic cancer	5.56e-05	0.0002	CcSEcCtD
Alosetron—Hyperhidrosis—Triamcinolone—hematologic cancer	5.56e-05	0.0002	CcSEcCtD
Alosetron—Headache—Thiotepa—hematologic cancer	5.53e-05	0.000199	CcSEcCtD
Alosetron—Hypertension—Betamethasone—hematologic cancer	5.52e-05	0.000198	CcSEcCtD
Alosetron—Hypertension—Dexamethasone—hematologic cancer	5.52e-05	0.000198	CcSEcCtD
Alosetron—Nausea—Vinorelbine—hematologic cancer	5.49e-05	0.000197	CcSEcCtD
Alosetron—Asthenia—Irinotecan—hematologic cancer	5.47e-05	0.000196	CcSEcCtD
Alosetron—Asthenia—Mitoxantrone—hematologic cancer	5.47e-05	0.000196	CcSEcCtD
Alosetron—Fatigue—Etoposide—hematologic cancer	5.46e-05	0.000196	CcSEcCtD
Alosetron—Myalgia—Dexamethasone—hematologic cancer	5.44e-05	0.000196	CcSEcCtD
Alosetron—Myalgia—Betamethasone—hematologic cancer	5.44e-05	0.000196	CcSEcCtD
Alosetron—Jaundice—Epirubicin—hematologic cancer	5.43e-05	0.000195	CcSEcCtD
Alosetron—Vomiting—Thalidomide—hematologic cancer	5.43e-05	0.000195	CcSEcCtD
Alosetron—Anxiety—Dexamethasone—hematologic cancer	5.42e-05	0.000195	CcSEcCtD
Alosetron—Anxiety—Betamethasone—hematologic cancer	5.42e-05	0.000195	CcSEcCtD
Alosetron—Pain—Etoposide—hematologic cancer	5.42e-05	0.000195	CcSEcCtD
Alosetron—Constipation—Etoposide—hematologic cancer	5.42e-05	0.000195	CcSEcCtD
Alosetron—Urinary tract infection—Epirubicin—hematologic cancer	5.41e-05	0.000195	CcSEcCtD
Alosetron—Rash—Thalidomide—hematologic cancer	5.38e-05	0.000193	CcSEcCtD
Alosetron—Discomfort—Dexamethasone—hematologic cancer	5.38e-05	0.000193	CcSEcCtD
Alosetron—Discomfort—Betamethasone—hematologic cancer	5.38e-05	0.000193	CcSEcCtD
Alosetron—Dermatitis—Thalidomide—hematologic cancer	5.38e-05	0.000193	CcSEcCtD
Alosetron—Upper respiratory tract infection—Doxorubicin—hematologic cancer	5.37e-05	0.000193	CcSEcCtD
Alosetron—Haemoglobin—Methotrexate—hematologic cancer	5.37e-05	0.000193	CcSEcCtD
Alosetron—Headache—Thalidomide—hematologic cancer	5.35e-05	0.000192	CcSEcCtD
Alosetron—Pain—Prednisolone—hematologic cancer	5.35e-05	0.000192	CcSEcCtD
Alosetron—Haemorrhage—Methotrexate—hematologic cancer	5.34e-05	0.000192	CcSEcCtD
Alosetron—Hepatitis—Methotrexate—hematologic cancer	5.34e-05	0.000192	CcSEcCtD
Alosetron—Sweating—Epirubicin—hematologic cancer	5.34e-05	0.000192	CcSEcCtD
Alosetron—Pollakiuria—Doxorubicin—hematologic cancer	5.34e-05	0.000192	CcSEcCtD
Alosetron—Asthenia—Gemcitabine—hematologic cancer	5.33e-05	0.000191	CcSEcCtD
Alosetron—Nausea—Thiotepa—hematologic cancer	5.24e-05	0.000188	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	5.24e-05	0.000188	CcSEcCtD
Alosetron—Sinusitis—Epirubicin—hematologic cancer	5.23e-05	0.000188	CcSEcCtD
Alosetron—Feeling abnormal—Etoposide—hematologic cancer	5.22e-05	0.000188	CcSEcCtD
Alosetron—Hyperglycaemia—Doxorubicin—hematologic cancer	5.21e-05	0.000187	CcSEcCtD
Alosetron—Vomiting—Carmustine—hematologic cancer	5.21e-05	0.000187	CcSEcCtD
Alosetron—Infection—Betamethasone—hematologic cancer	5.18e-05	0.000186	CcSEcCtD
Alosetron—Infection—Dexamethasone—hematologic cancer	5.18e-05	0.000186	CcSEcCtD
Alosetron—Rash—Carmustine—hematologic cancer	5.17e-05	0.000186	CcSEcCtD
Alosetron—Ill-defined disorder—Prednisone—hematologic cancer	5.16e-05	0.000186	CcSEcCtD
Alosetron—Dermatitis—Carmustine—hematologic cancer	5.16e-05	0.000186	CcSEcCtD
Alosetron—Vomiting—Alitretinoin—hematologic cancer	5.16e-05	0.000186	CcSEcCtD
Alosetron—Feeling abnormal—Prednisolone—hematologic cancer	5.15e-05	0.000185	CcSEcCtD
Alosetron—Headache—Carmustine—hematologic cancer	5.13e-05	0.000185	CcSEcCtD
Alosetron—Rash—Alitretinoin—hematologic cancer	5.12e-05	0.000184	CcSEcCtD
Alosetron—Dermatitis—Alitretinoin—hematologic cancer	5.11e-05	0.000184	CcSEcCtD
Alosetron—Vomiting—Ifosfamide—hematologic cancer	5.1e-05	0.000183	CcSEcCtD
Alosetron—Hypersensitivity—Cisplatin—hematologic cancer	5.1e-05	0.000183	CcSEcCtD
Alosetron—Headache—Alitretinoin—hematologic cancer	5.09e-05	0.000183	CcSEcCtD
Alosetron—Nausea—Thalidomide—hematologic cancer	5.07e-05	0.000182	CcSEcCtD
Alosetron—Rash—Ifosfamide—hematologic cancer	5.06e-05	0.000182	CcSEcCtD
Alosetron—Dermatitis—Ifosfamide—hematologic cancer	5.05e-05	0.000182	CcSEcCtD
Alosetron—Hyperhidrosis—Betamethasone—hematologic cancer	5.04e-05	0.000181	CcSEcCtD
Alosetron—Hyperhidrosis—Dexamethasone—hematologic cancer	5.04e-05	0.000181	CcSEcCtD
Alosetron—Urticaria—Etoposide—hematologic cancer	5.03e-05	0.000181	CcSEcCtD
Alosetron—Haemoglobin—Epirubicin—hematologic cancer	5.03e-05	0.000181	CcSEcCtD
Alosetron—Jaundice—Doxorubicin—hematologic cancer	5.02e-05	0.000181	CcSEcCtD
Alosetron—Malaise—Prednisone—hematologic cancer	5.02e-05	0.00018	CcSEcCtD
Alosetron—Urinary tract infection—Doxorubicin—hematologic cancer	5.01e-05	0.00018	CcSEcCtD
Alosetron—Hepatitis—Epirubicin—hematologic cancer	5e-05	0.00018	CcSEcCtD
Alosetron—Haemorrhage—Epirubicin—hematologic cancer	5e-05	0.00018	CcSEcCtD
Alosetron—Hypoaesthesia—Epirubicin—hematologic cancer	4.98e-05	0.000179	CcSEcCtD
Alosetron—Vomiting—Vincristine—hematologic cancer	4.97e-05	0.000179	CcSEcCtD
Alosetron—Urticaria—Prednisolone—hematologic cancer	4.97e-05	0.000178	CcSEcCtD
Alosetron—Asthenia—Cisplatin—hematologic cancer	4.96e-05	0.000178	CcSEcCtD
Alosetron—Fatigue—Triamcinolone—hematologic cancer	4.96e-05	0.000178	CcSEcCtD
Alosetron—Sweating—Doxorubicin—hematologic cancer	4.94e-05	0.000178	CcSEcCtD
Alosetron—Rash—Vincristine—hematologic cancer	4.93e-05	0.000177	CcSEcCtD
Alosetron—Dermatitis—Vincristine—hematologic cancer	4.93e-05	0.000177	CcSEcCtD
Alosetron—Pain—Triamcinolone—hematologic cancer	4.92e-05	0.000177	CcSEcCtD
Alosetron—Headache—Vincristine—hematologic cancer	4.9e-05	0.000176	CcSEcCtD
Alosetron—Nausea—Carmustine—hematologic cancer	4.87e-05	0.000175	CcSEcCtD
Alosetron—Vomiting—Irinotecan—hematologic cancer	4.84e-05	0.000174	CcSEcCtD
Alosetron—Vomiting—Mitoxantrone—hematologic cancer	4.84e-05	0.000174	CcSEcCtD
Alosetron—Sinusitis—Doxorubicin—hematologic cancer	4.84e-05	0.000174	CcSEcCtD
Alosetron—Nausea—Alitretinoin—hematologic cancer	4.82e-05	0.000173	CcSEcCtD
Alosetron—Hypertension—Prednisone—hematologic cancer	4.81e-05	0.000173	CcSEcCtD
Alosetron—Rash—Mitoxantrone—hematologic cancer	4.8e-05	0.000173	CcSEcCtD
Alosetron—Rash—Irinotecan—hematologic cancer	4.8e-05	0.000173	CcSEcCtD
Alosetron—Dermatitis—Mitoxantrone—hematologic cancer	4.8e-05	0.000173	CcSEcCtD
Alosetron—Dermatitis—Irinotecan—hematologic cancer	4.8e-05	0.000173	CcSEcCtD
Alosetron—Headache—Mitoxantrone—hematologic cancer	4.77e-05	0.000172	CcSEcCtD
Alosetron—Headache—Irinotecan—hematologic cancer	4.77e-05	0.000172	CcSEcCtD
Alosetron—Nausea—Ifosfamide—hematologic cancer	4.77e-05	0.000171	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	4.75e-05	0.000171	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Betamethasone—hematologic cancer	4.75e-05	0.000171	CcSEcCtD
Alosetron—Myalgia—Prednisone—hematologic cancer	4.74e-05	0.00017	CcSEcCtD
Alosetron—Feeling abnormal—Triamcinolone—hematologic cancer	4.74e-05	0.00017	CcSEcCtD
Alosetron—Anxiety—Prednisone—hematologic cancer	4.72e-05	0.00017	CcSEcCtD
Alosetron—Alopecia—Methotrexate—hematologic cancer	4.72e-05	0.00017	CcSEcCtD
Alosetron—Vomiting—Gemcitabine—hematologic cancer	4.72e-05	0.00017	CcSEcCtD
Alosetron—Discomfort—Prednisone—hematologic cancer	4.68e-05	0.000168	CcSEcCtD
Alosetron—Rash—Gemcitabine—hematologic cancer	4.68e-05	0.000168	CcSEcCtD
Alosetron—Dermatitis—Gemcitabine—hematologic cancer	4.68e-05	0.000168	CcSEcCtD
Alosetron—Hypersensitivity—Etoposide—hematologic cancer	4.67e-05	0.000168	CcSEcCtD
Alosetron—Haemoglobin—Doxorubicin—hematologic cancer	4.65e-05	0.000167	CcSEcCtD
Alosetron—Headache—Gemcitabine—hematologic cancer	4.65e-05	0.000167	CcSEcCtD
Alosetron—Nausea—Vincristine—hematologic cancer	4.65e-05	0.000167	CcSEcCtD
Alosetron—Haemorrhage—Doxorubicin—hematologic cancer	4.63e-05	0.000166	CcSEcCtD
Alosetron—Hepatitis—Doxorubicin—hematologic cancer	4.63e-05	0.000166	CcSEcCtD
Alosetron—Hypersensitivity—Prednisolone—hematologic cancer	4.61e-05	0.000166	CcSEcCtD
Alosetron—Hypoaesthesia—Doxorubicin—hematologic cancer	4.6e-05	0.000165	CcSEcCtD
Alosetron—Urticaria—Triamcinolone—hematologic cancer	4.57e-05	0.000164	CcSEcCtD
Alosetron—Asthenia—Etoposide—hematologic cancer	4.55e-05	0.000163	CcSEcCtD
Alosetron—Nausea—Mitoxantrone—hematologic cancer	4.53e-05	0.000163	CcSEcCtD
Alosetron—Nausea—Irinotecan—hematologic cancer	4.53e-05	0.000163	CcSEcCtD
Alosetron—Infection—Prednisone—hematologic cancer	4.51e-05	0.000162	CcSEcCtD
Alosetron—Fatigue—Dexamethasone—hematologic cancer	4.5e-05	0.000162	CcSEcCtD
Alosetron—Fatigue—Betamethasone—hematologic cancer	4.5e-05	0.000162	CcSEcCtD
Alosetron—Arrhythmia—Epirubicin—hematologic cancer	4.47e-05	0.000161	CcSEcCtD
Alosetron—Pain—Betamethasone—hematologic cancer	4.46e-05	0.00016	CcSEcCtD
Alosetron—Pain—Dexamethasone—hematologic cancer	4.46e-05	0.00016	CcSEcCtD
Alosetron—Alopecia—Epirubicin—hematologic cancer	4.42e-05	0.000159	CcSEcCtD
Alosetron—Skin disorder—Prednisone—hematologic cancer	4.41e-05	0.000159	CcSEcCtD
Alosetron—Nausea—Gemcitabine—hematologic cancer	4.41e-05	0.000158	CcSEcCtD
Alosetron—Vomiting—Cisplatin—hematologic cancer	4.4e-05	0.000158	CcSEcCtD
Alosetron—Hyperhidrosis—Prednisone—hematologic cancer	4.39e-05	0.000158	CcSEcCtD
Alosetron—Rash—Cisplatin—hematologic cancer	4.36e-05	0.000157	CcSEcCtD
Alosetron—Dermatitis—Cisplatin—hematologic cancer	4.36e-05	0.000157	CcSEcCtD
Alosetron—Ill-defined disorder—Methotrexate—hematologic cancer	4.32e-05	0.000155	CcSEcCtD
Alosetron—Feeling abnormal—Dexamethasone—hematologic cancer	4.3e-05	0.000154	CcSEcCtD
Alosetron—Feeling abnormal—Betamethasone—hematologic cancer	4.3e-05	0.000154	CcSEcCtD
Alosetron—Flatulence—Epirubicin—hematologic cancer	4.29e-05	0.000154	CcSEcCtD
Alosetron—Hypersensitivity—Triamcinolone—hematologic cancer	4.24e-05	0.000152	CcSEcCtD
Alosetron—Malaise—Methotrexate—hematologic cancer	4.19e-05	0.000151	CcSEcCtD
Alosetron—Muscle spasms—Epirubicin—hematologic cancer	4.19e-05	0.00015	CcSEcCtD
Alosetron—Urticaria—Betamethasone—hematologic cancer	4.14e-05	0.000149	CcSEcCtD
Alosetron—Urticaria—Dexamethasone—hematologic cancer	4.14e-05	0.000149	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.14e-05	0.000149	CcSEcCtD
Alosetron—Arrhythmia—Doxorubicin—hematologic cancer	4.13e-05	0.000149	CcSEcCtD
Alosetron—Asthenia—Triamcinolone—hematologic cancer	4.12e-05	0.000148	CcSEcCtD
Alosetron—Nausea—Cisplatin—hematologic cancer	4.11e-05	0.000148	CcSEcCtD
Alosetron—Alopecia—Doxorubicin—hematologic cancer	4.09e-05	0.000147	CcSEcCtD
Alosetron—Cough—Methotrexate—hematologic cancer	4.06e-05	0.000146	CcSEcCtD
Alosetron—Ill-defined disorder—Epirubicin—hematologic cancer	4.04e-05	0.000145	CcSEcCtD
Alosetron—Vomiting—Etoposide—hematologic cancer	4.03e-05	0.000145	CcSEcCtD
Alosetron—Rash—Etoposide—hematologic cancer	4e-05	0.000144	CcSEcCtD
Alosetron—Dermatitis—Etoposide—hematologic cancer	3.99e-05	0.000143	CcSEcCtD
Alosetron—Headache—Etoposide—hematologic cancer	3.97e-05	0.000143	CcSEcCtD
Alosetron—Flatulence—Doxorubicin—hematologic cancer	3.97e-05	0.000143	CcSEcCtD
Alosetron—Myalgia—Methotrexate—hematologic cancer	3.96e-05	0.000142	CcSEcCtD
Alosetron—Rash—Prednisolone—hematologic cancer	3.94e-05	0.000142	CcSEcCtD
Alosetron—Dermatitis—Prednisolone—hematologic cancer	3.94e-05	0.000142	CcSEcCtD
Alosetron—Malaise—Epirubicin—hematologic cancer	3.93e-05	0.000141	CcSEcCtD
Alosetron—Fatigue—Prednisone—hematologic cancer	3.92e-05	0.000141	CcSEcCtD
Alosetron—Headache—Prednisolone—hematologic cancer	3.92e-05	0.000141	CcSEcCtD
Alosetron—Discomfort—Methotrexate—hematologic cancer	3.91e-05	0.000141	CcSEcCtD
Alosetron—Constipation—Prednisone—hematologic cancer	3.88e-05	0.00014	CcSEcCtD
Alosetron—Muscle spasms—Doxorubicin—hematologic cancer	3.87e-05	0.000139	CcSEcCtD
Alosetron—Confusional state—Methotrexate—hematologic cancer	3.83e-05	0.000138	CcSEcCtD
Alosetron—Cough—Epirubicin—hematologic cancer	3.8e-05	0.000137	CcSEcCtD
Alosetron—Infection—Methotrexate—hematologic cancer	3.77e-05	0.000136	CcSEcCtD
Alosetron—Nausea—Etoposide—hematologic cancer	3.76e-05	0.000135	CcSEcCtD
Alosetron—Hypertension—Epirubicin—hematologic cancer	3.76e-05	0.000135	CcSEcCtD
Alosetron—Feeling abnormal—Prednisone—hematologic cancer	3.74e-05	0.000135	CcSEcCtD
Alosetron—Asthenia—Dexamethasone—hematologic cancer	3.74e-05	0.000135	CcSEcCtD
Alosetron—Asthenia—Betamethasone—hematologic cancer	3.74e-05	0.000135	CcSEcCtD
Alosetron—Ill-defined disorder—Doxorubicin—hematologic cancer	3.74e-05	0.000134	CcSEcCtD
Alosetron—Nausea—Prednisolone—hematologic cancer	3.71e-05	0.000133	CcSEcCtD
Alosetron—Myalgia—Epirubicin—hematologic cancer	3.71e-05	0.000133	CcSEcCtD
Alosetron—Anxiety—Epirubicin—hematologic cancer	3.69e-05	0.000133	CcSEcCtD
Alosetron—Skin disorder—Methotrexate—hematologic cancer	3.69e-05	0.000133	CcSEcCtD
Alosetron—Hyperhidrosis—Methotrexate—hematologic cancer	3.67e-05	0.000132	CcSEcCtD
Alosetron—Discomfort—Epirubicin—hematologic cancer	3.66e-05	0.000132	CcSEcCtD
Alosetron—Vomiting—Triamcinolone—hematologic cancer	3.65e-05	0.000131	CcSEcCtD
Alosetron—Malaise—Doxorubicin—hematologic cancer	3.63e-05	0.000131	CcSEcCtD
Alosetron—Rash—Triamcinolone—hematologic cancer	3.62e-05	0.00013	CcSEcCtD
Alosetron—Dry mouth—Epirubicin—hematologic cancer	3.62e-05	0.00013	CcSEcCtD
Alosetron—Dermatitis—Triamcinolone—hematologic cancer	3.62e-05	0.00013	CcSEcCtD
Alosetron—Urticaria—Prednisone—hematologic cancer	3.61e-05	0.00013	CcSEcCtD
Alosetron—Headache—Triamcinolone—hematologic cancer	3.6e-05	0.000129	CcSEcCtD
Alosetron—Confusional state—Epirubicin—hematologic cancer	3.58e-05	0.000129	CcSEcCtD
Alosetron—Infection—Epirubicin—hematologic cancer	3.53e-05	0.000127	CcSEcCtD
Alosetron—Cough—Doxorubicin—hematologic cancer	3.51e-05	0.000126	CcSEcCtD
Alosetron—Hypertension—Doxorubicin—hematologic cancer	3.48e-05	0.000125	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.46e-05	0.000124	CcSEcCtD
Alosetron—Skin disorder—Epirubicin—hematologic cancer	3.45e-05	0.000124	CcSEcCtD
Alosetron—Hyperhidrosis—Epirubicin—hematologic cancer	3.43e-05	0.000123	CcSEcCtD
Alosetron—Myalgia—Doxorubicin—hematologic cancer	3.43e-05	0.000123	CcSEcCtD
Alosetron—Anxiety—Doxorubicin—hematologic cancer	3.42e-05	0.000123	CcSEcCtD
Alosetron—Nausea—Triamcinolone—hematologic cancer	3.41e-05	0.000123	CcSEcCtD
Alosetron—Discomfort—Doxorubicin—hematologic cancer	3.39e-05	0.000122	CcSEcCtD
Alosetron—Dry mouth—Doxorubicin—hematologic cancer	3.35e-05	0.000121	CcSEcCtD
Alosetron—Hypersensitivity—Prednisone—hematologic cancer	3.35e-05	0.00012	CcSEcCtD
Alosetron—Vomiting—Dexamethasone—hematologic cancer	3.32e-05	0.000119	CcSEcCtD
Alosetron—Vomiting—Betamethasone—hematologic cancer	3.32e-05	0.000119	CcSEcCtD
Alosetron—Confusional state—Doxorubicin—hematologic cancer	3.31e-05	0.000119	CcSEcCtD
Alosetron—Rash—Dexamethasone—hematologic cancer	3.29e-05	0.000118	CcSEcCtD
Alosetron—Rash—Betamethasone—hematologic cancer	3.29e-05	0.000118	CcSEcCtD
Alosetron—Dermatitis—Dexamethasone—hematologic cancer	3.29e-05	0.000118	CcSEcCtD
Alosetron—Dermatitis—Betamethasone—hematologic cancer	3.29e-05	0.000118	CcSEcCtD
Alosetron—Fatigue—Methotrexate—hematologic cancer	3.27e-05	0.000118	CcSEcCtD
Alosetron—Headache—Betamethasone—hematologic cancer	3.27e-05	0.000117	CcSEcCtD
Alosetron—Headache—Dexamethasone—hematologic cancer	3.27e-05	0.000117	CcSEcCtD
Alosetron—Infection—Doxorubicin—hematologic cancer	3.27e-05	0.000117	CcSEcCtD
Alosetron—Asthenia—Prednisone—hematologic cancer	3.26e-05	0.000117	CcSEcCtD
Alosetron—Pain—Methotrexate—hematologic cancer	3.25e-05	0.000117	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.24e-05	0.000116	CcSEcCtD
Alosetron—Skin disorder—Doxorubicin—hematologic cancer	3.19e-05	0.000115	CcSEcCtD
Alosetron—Hyperhidrosis—Doxorubicin—hematologic cancer	3.18e-05	0.000114	CcSEcCtD
Alosetron—Feeling abnormal—Methotrexate—hematologic cancer	3.13e-05	0.000112	CcSEcCtD
Alosetron—Nausea—Dexamethasone—hematologic cancer	3.1e-05	0.000111	CcSEcCtD
Alosetron—Nausea—Betamethasone—hematologic cancer	3.1e-05	0.000111	CcSEcCtD
Alosetron—Fatigue—Epirubicin—hematologic cancer	3.06e-05	0.00011	CcSEcCtD
Alosetron—Pain—Epirubicin—hematologic cancer	3.04e-05	0.000109	CcSEcCtD
Alosetron—Constipation—Epirubicin—hematologic cancer	3.04e-05	0.000109	CcSEcCtD
Alosetron—Urticaria—Methotrexate—hematologic cancer	3.02e-05	0.000108	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.99e-05	0.000108	CcSEcCtD
Alosetron—Feeling abnormal—Epirubicin—hematologic cancer	2.93e-05	0.000105	CcSEcCtD
Alosetron—Vomiting—Prednisone—hematologic cancer	2.89e-05	0.000104	CcSEcCtD
Alosetron—Rash—Prednisone—hematologic cancer	2.86e-05	0.000103	CcSEcCtD
Alosetron—Dermatitis—Prednisone—hematologic cancer	2.86e-05	0.000103	CcSEcCtD
Alosetron—Headache—Prednisone—hematologic cancer	2.85e-05	0.000102	CcSEcCtD
Alosetron—Fatigue—Doxorubicin—hematologic cancer	2.83e-05	0.000102	CcSEcCtD
Alosetron—Urticaria—Epirubicin—hematologic cancer	2.82e-05	0.000101	CcSEcCtD
Alosetron—Pain—Doxorubicin—hematologic cancer	2.81e-05	0.000101	CcSEcCtD
Alosetron—Constipation—Doxorubicin—hematologic cancer	2.81e-05	0.000101	CcSEcCtD
Alosetron—Hypersensitivity—Methotrexate—hematologic cancer	2.8e-05	0.000101	CcSEcCtD
Alosetron—Asthenia—Methotrexate—hematologic cancer	2.72e-05	9.79e-05	CcSEcCtD
Alosetron—Feeling abnormal—Doxorubicin—hematologic cancer	2.71e-05	9.74e-05	CcSEcCtD
Alosetron—Nausea—Prednisone—hematologic cancer	2.7e-05	9.7e-05	CcSEcCtD
Alosetron—Hypersensitivity—Epirubicin—hematologic cancer	2.62e-05	9.41e-05	CcSEcCtD
Alosetron—Urticaria—Doxorubicin—hematologic cancer	2.61e-05	9.39e-05	CcSEcCtD
Alosetron—Asthenia—Epirubicin—hematologic cancer	2.55e-05	9.16e-05	CcSEcCtD
Alosetron—Hypersensitivity—Doxorubicin—hematologic cancer	2.42e-05	8.7e-05	CcSEcCtD
Alosetron—Vomiting—Methotrexate—hematologic cancer	2.41e-05	8.68e-05	CcSEcCtD
Alosetron—Rash—Methotrexate—hematologic cancer	2.39e-05	8.6e-05	CcSEcCtD
Alosetron—Dermatitis—Methotrexate—hematologic cancer	2.39e-05	8.59e-05	CcSEcCtD
Alosetron—Headache—Methotrexate—hematologic cancer	2.38e-05	8.55e-05	CcSEcCtD
Alosetron—Asthenia—Doxorubicin—hematologic cancer	2.36e-05	8.48e-05	CcSEcCtD
Alosetron—Vomiting—Epirubicin—hematologic cancer	2.26e-05	8.12e-05	CcSEcCtD
Alosetron—Nausea—Methotrexate—hematologic cancer	2.25e-05	8.1e-05	CcSEcCtD
Alosetron—Rash—Epirubicin—hematologic cancer	2.24e-05	8.05e-05	CcSEcCtD
Alosetron—Dermatitis—Epirubicin—hematologic cancer	2.24e-05	8.04e-05	CcSEcCtD
Alosetron—Headache—Epirubicin—hematologic cancer	2.23e-05	8e-05	CcSEcCtD
Alosetron—Nausea—Epirubicin—hematologic cancer	2.11e-05	7.58e-05	CcSEcCtD
Alosetron—Vomiting—Doxorubicin—hematologic cancer	2.09e-05	7.51e-05	CcSEcCtD
Alosetron—Rash—Doxorubicin—hematologic cancer	2.07e-05	7.45e-05	CcSEcCtD
Alosetron—Dermatitis—Doxorubicin—hematologic cancer	2.07e-05	7.44e-05	CcSEcCtD
Alosetron—Headache—Doxorubicin—hematologic cancer	2.06e-05	7.4e-05	CcSEcCtD
Alosetron—Nausea—Doxorubicin—hematologic cancer	1.95e-05	7.02e-05	CcSEcCtD
Alosetron—CYP1A2—Metabolism—FTCD—hematologic cancer	1.39e-05	0.000607	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PHYH—hematologic cancer	1.39e-05	0.000607	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.39e-05	0.000606	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.38e-05	0.000603	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.38e-05	0.000601	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—MTAP—hematologic cancer	1.37e-05	0.000595	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.36e-05	0.00059	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.31e-05	0.000572	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ASNS—hematologic cancer	1.3e-05	0.000568	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—DCK—hematologic cancer	1.3e-05	0.000568	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—B3GAT1—hematologic cancer	1.3e-05	0.000568	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.3e-05	0.000566	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.29e-05	0.000562	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SMPD3—hematologic cancer	1.27e-05	0.000555	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.27e-05	0.000555	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.27e-05	0.000554	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.27e-05	0.000554	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HDC—hematologic cancer	1.24e-05	0.000538	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—FHL2—hematologic cancer	1.22e-05	0.00053	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—AGRN—hematologic cancer	1.19e-05	0.00052	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.19e-05	0.000518	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.16e-05	0.000504	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.15e-05	0.000502	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—IDH2—hematologic cancer	1.13e-05	0.000493	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—HMMR—hematologic cancer	1.13e-05	0.000493	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CDA—hematologic cancer	1.13e-05	0.000492	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—B3GAT1—hematologic cancer	1.11e-05	0.000485	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—DCK—hematologic cancer	1.11e-05	0.000485	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ASNS—hematologic cancer	1.11e-05	0.000485	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.09e-05	0.000474	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PC—hematologic cancer	1.09e-05	0.000474	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PHYH—hematologic cancer	1.08e-05	0.000468	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GMPS—hematologic cancer	1.08e-05	0.000468	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—FTCD—hematologic cancer	1.08e-05	0.000468	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ARNTL—hematologic cancer	1.06e-05	0.000464	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HDC—hematologic cancer	1.06e-05	0.00046	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GBA—hematologic cancer	1.05e-05	0.000458	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SLC35B2—hematologic cancer	1.05e-05	0.000458	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ACP5—hematologic cancer	1.04e-05	0.000451	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CA9—hematologic cancer	1.04e-05	0.000451	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NCOR2—hematologic cancer	1.02e-05	0.000445	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	9.85e-06	0.000429	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SMPD3—hematologic cancer	9.84e-06	0.000428	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—IDH1—hematologic cancer	9.74e-06	0.000424	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CDA—hematologic cancer	9.66e-06	0.000421	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ABCC3—hematologic cancer	9.63e-06	0.000419	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTO1—hematologic cancer	9.63e-06	0.000419	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—TXN—hematologic cancer	9.63e-06	0.000419	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MTAP—hematologic cancer	9.61e-06	0.000419	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—SPHK1—hematologic cancer	9.42e-06	0.00041	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PC—hematologic cancer	9.3e-06	0.000405	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—UGT1A1—hematologic cancer	9.05e-06	0.000394	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GBA—hematologic cancer	8.98e-06	0.000391	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SLC35B2—hematologic cancer	8.98e-06	0.000391	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CRABP1—hematologic cancer	8.8e-06	0.000383	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—SLC22A1—hematologic cancer	8.8e-06	0.000383	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ASNS—hematologic cancer	8.6e-06	0.000375	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—DCK—hematologic cancer	8.6e-06	0.000375	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—B3GAT1—hematologic cancer	8.6e-06	0.000375	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ALOX5—hematologic cancer	8.58e-06	0.000374	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—FHL2—hematologic cancer	8.57e-06	0.000373	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—AGRN—hematologic cancer	8.4e-06	0.000366	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NUP98—hematologic cancer	8.31e-06	0.000362	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MTAP—hematologic cancer	8.21e-06	0.000358	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HDC—hematologic cancer	8.15e-06	0.000355	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NCOA3—hematologic cancer	8.07e-06	0.000351	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ADCY7—hematologic cancer	8.07e-06	0.000351	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NUP214—hematologic cancer	8.01e-06	0.000349	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—IDH2—hematologic cancer	7.96e-06	0.000347	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HMMR—hematologic cancer	7.96e-06	0.000347	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—MTR—hematologic cancer	7.85e-06	0.000342	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ABCG2—hematologic cancer	7.85e-06	0.000342	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ENO2—hematologic cancer	7.7e-06	0.000335	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.51e-06	0.000327	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ARNTL—hematologic cancer	7.49e-06	0.000326	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTT1—hematologic cancer	7.46e-06	0.000325	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CDA—hematologic cancer	7.45e-06	0.000325	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—FHL2—hematologic cancer	7.32e-06	0.000319	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—SDC1—hematologic cancer	7.3e-06	0.000318	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CA9—hematologic cancer	7.28e-06	0.000317	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ACP5—hematologic cancer	7.28e-06	0.000317	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NCOR2—hematologic cancer	7.19e-06	0.000313	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—AGRN—hematologic cancer	7.18e-06	0.000313	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PC—hematologic cancer	7.18e-06	0.000313	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GBA—hematologic cancer	6.93e-06	0.000302	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SLC35B2—hematologic cancer	6.93e-06	0.000302	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—IDH1—hematologic cancer	6.85e-06	0.000298	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—IDH2—hematologic cancer	6.81e-06	0.000296	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HMMR—hematologic cancer	6.81e-06	0.000296	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTO1—hematologic cancer	6.77e-06	0.000295	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ABCC3—hematologic cancer	6.77e-06	0.000295	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—TXN—hematologic cancer	6.77e-06	0.000295	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SPHK1—hematologic cancer	6.63e-06	0.000289	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.42e-06	0.00028	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ARNTL—hematologic cancer	6.4e-06	0.000279	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—UGT1A1—hematologic cancer	6.37e-06	0.000277	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MTAP—hematologic cancer	6.34e-06	0.000276	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CA9—hematologic cancer	6.22e-06	0.000271	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ACP5—hematologic cancer	6.22e-06	0.000271	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NQO1—hematologic cancer	6.2e-06	0.00027	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CD44—hematologic cancer	6.2e-06	0.00027	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SLC22A1—hematologic cancer	6.19e-06	0.00027	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CRABP1—hematologic cancer	6.19e-06	0.00027	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NCOR2—hematologic cancer	6.14e-06	0.000268	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALOX5—hematologic cancer	6.04e-06	0.000263	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYCS—hematologic cancer	5.87e-06	0.000256	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—IDH1—hematologic cancer	5.85e-06	0.000255	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NUP98—hematologic cancer	5.85e-06	0.000255	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	5.83e-06	0.000254	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ABCC3—hematologic cancer	5.79e-06	0.000252	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTO1—hematologic cancer	5.79e-06	0.000252	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—TXN—hematologic cancer	5.79e-06	0.000252	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ADCY7—hematologic cancer	5.67e-06	0.000247	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NCOA3—hematologic cancer	5.67e-06	0.000247	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SPHK1—hematologic cancer	5.66e-06	0.000247	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—FHL2—hematologic cancer	5.65e-06	0.000246	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NUP214—hematologic cancer	5.63e-06	0.000245	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.58e-06	0.000243	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—AGRN—hematologic cancer	5.54e-06	0.000241	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MTR—hematologic cancer	5.52e-06	0.00024	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ABCG2—hematologic cancer	5.52e-06	0.00024	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—UGT1A1—hematologic cancer	5.44e-06	0.000237	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ENO2—hematologic cancer	5.41e-06	0.000236	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SLC22A1—hematologic cancer	5.29e-06	0.000231	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CRABP1—hematologic cancer	5.29e-06	0.000231	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HMMR—hematologic cancer	5.25e-06	0.000229	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—IDH2—hematologic cancer	5.25e-06	0.000229	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTT1—hematologic cancer	5.25e-06	0.000229	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTP1—hematologic cancer	5.17e-06	0.000225	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.17e-06	0.000225	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALOX5—hematologic cancer	5.16e-06	0.000225	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SDC1—hematologic cancer	5.13e-06	0.000224	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NUP98—hematologic cancer	5e-06	0.000218	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.94e-06	0.000215	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.9e-06	0.000214	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ABCB1—hematologic cancer	4.9e-06	0.000213	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.85e-06	0.000211	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.85e-06	0.000211	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.84e-06	0.000211	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NUP214—hematologic cancer	4.82e-06	0.00021	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CA9—hematologic cancer	4.8e-06	0.000209	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ACP5—hematologic cancer	4.8e-06	0.000209	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.77e-06	0.000208	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NCOR1—hematologic cancer	4.75e-06	0.000207	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTM1—hematologic cancer	4.75e-06	0.000207	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.74e-06	0.000207	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MTR—hematologic cancer	4.72e-06	0.000205	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ABCG2—hematologic cancer	4.72e-06	0.000205	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.63e-06	0.000202	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ENO2—hematologic cancer	4.63e-06	0.000201	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—IDH1—hematologic cancer	4.52e-06	0.000197	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTT1—hematologic cancer	4.49e-06	0.000195	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.47e-06	0.000195	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—TXN—hematologic cancer	4.47e-06	0.000195	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.47e-06	0.000195	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.42e-06	0.000192	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SDC1—hematologic cancer	4.39e-06	0.000191	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.37e-06	0.00019	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NQO1—hematologic cancer	4.36e-06	0.00019	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CD44—hematologic cancer	4.36e-06	0.00019	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.27e-06	0.000186	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—MTHFR—hematologic cancer	4.2e-06	0.000183	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.2e-06	0.000183	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.19e-06	0.000182	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.14e-06	0.00018	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYCS—hematologic cancer	4.13e-06	0.00018	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.1e-06	0.000179	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.08e-06	0.000178	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.08e-06	0.000178	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.98e-06	0.000173	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.96e-06	0.000172	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NUP98—hematologic cancer	3.86e-06	0.000168	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.74e-06	0.000163	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.74e-06	0.000163	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NQO1—hematologic cancer	3.73e-06	0.000162	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CD44—hematologic cancer	3.73e-06	0.000162	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NUP214—hematologic cancer	3.72e-06	0.000162	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.69e-06	0.000161	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.65e-06	0.000159	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.64e-06	0.000159	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MTR—hematologic cancer	3.64e-06	0.000159	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.64e-06	0.000159	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ENO2—hematologic cancer	3.57e-06	0.000156	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CG—hematologic cancer	3.53e-06	0.000154	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYCS—hematologic cancer	3.53e-06	0.000154	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.52e-06	0.000153	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.51e-06	0.000153	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.46e-06	0.000151	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.45e-06	0.00015	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SDC1—hematologic cancer	3.38e-06	0.000147	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.34e-06	0.000146	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.34e-06	0.000146	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CREBBP—hematologic cancer	3.27e-06	0.000143	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.16e-06	0.000137	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.11e-06	0.000135	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CD—hematologic cancer	3.1e-06	0.000135	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ALB—hematologic cancer	3.06e-06	0.000133	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.01e-06	0.000131	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.96e-06	0.000129	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.94e-06	0.000128	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3R1—hematologic cancer	2.93e-06	0.000128	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CD44—hematologic cancer	2.88e-06	0.000125	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NQO1—hematologic cancer	2.88e-06	0.000125	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.86e-06	0.000124	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.86e-06	0.000124	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYCS—hematologic cancer	2.72e-06	0.000119	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.71e-06	0.000118	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CB—hematologic cancer	2.71e-06	0.000118	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.6e-06	0.000113	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.53e-06	0.00011	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.48e-06	0.000108	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.4e-06	0.000105	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PTEN—hematologic cancer	2.34e-06	0.000102	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.3e-06	0.0001	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.27e-06	9.9e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—EP300—hematologic cancer	2.23e-06	9.71e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.23e-06	9.7e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.21e-06	9.61e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.21e-06	9.61e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.18e-06	9.51e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALB—hematologic cancer	2.16e-06	9.39e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.12e-06	9.24e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.06e-06	8.98e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.97e-06	8.57e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.95e-06	8.49e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.9e-06	8.29e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.87e-06	8.13e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALB—hematologic cancer	1.84e-06	8.02e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.76e-06	7.67e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.65e-06	7.18e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PTEN—hematologic cancer	1.64e-06	7.16e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.64e-06	7.13e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.63e-06	7.08e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—EP300—hematologic cancer	1.57e-06	6.83e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.52e-06	6.61e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.44e-06	6.27e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALB—hematologic cancer	1.42e-06	6.19e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PTEN—hematologic cancer	1.41e-06	6.12e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.36e-06	5.92e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—AKT1—hematologic cancer	1.35e-06	5.87e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—EP300—hematologic cancer	1.34e-06	5.84e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.25e-06	5.47e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.16e-06	5.05e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PTEN—hematologic cancer	1.08e-06	4.72e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—EP300—hematologic cancer	1.03e-06	4.5e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CA—hematologic cancer	9.91e-07	4.32e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—AKT1—hematologic cancer	9.48e-07	4.13e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—AKT1—hematologic cancer	8.1e-07	3.53e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.65e-07	3.33e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—AKT1—hematologic cancer	6.25e-07	2.72e-05	CbGpPWpGaD
